Image source: © Lovelyday12 | Megapixl.com
Highlights
- Nufarm is an Australian company engaged in delivering seed technology and crop protection solutions
- The company expects to achieve or exceed its FY26 revenue target of AUD 4.6 billion
- Allan Gray Australia Pty Ltd has the maximum stake in the company with 14.05% shares
Nufarm Limited (ASX: NUF) develops and manufactures beyond YieldTM seed technologies and crop protection solutions. The seed technologies business is spread across 30 countries, and the crop protection business is present in Asia Pacific, North America, Middle East & Africa and Europe.
During the first half of 2023 (1HFY23), Nufarm achieved significant strategic milestones such as product launches, new agreements and growth in geographical footprint. In 1HFY23, the revenue fell by 9.7% over the previous corresponding period (pcp) to AUD 1,954.5 million, driven by a fall in demand as prices increased due to supply uncertainty. While the underlying net profit after tax increased by nearly 7% during the reported period due to favourable agricultural commodity prices.
uEBITDA from the seed technologies business grew by 34.4% to AUD 61.8 million in 1HFY23, backed by the increase in demand amid high grain prices and favourable seasonal conditions.
While releasing the half yearly results, Nufarm announced an interim dividend of 5 cents per share, up by 25% over the previous year. The dividend ex-date was 25 May 2023, and the pay date was 9 June 2023.
Top 10 shareholders of NUF
The top 10 shareholders of Nufarm together have ~53.98% shareholding in the company, and the top 4 shareholders have ~36.87% shareholding. The top four shareholders are Allan Gray Australia Pty Ltd, L1 Capital Pty Ltd., Phoenix Holdings Ltd and Host-Plus Pty Limited.

Recent business update
Nufarm shared via an ASX filing dated 29 June 2023 that it has received approval from the Norwegian Food Safety Authority (NFSA) for its Aquaterra Omega-3 oil for use in fish feed. Aquaterra is procured from Nuseed Omega-3 Canola. Nuseed is a division of NUF that commercialises and develops plant-based Omega-3.

Outlook
NUF said that by FY26, it expects to report revenue of over AUD 4.6 billion. The company intends to achieve the targeted revenue by evolving its portfolio by incorporating a higher percentage of innovative, higher margin and higher growth products.
In FY23, the company anticipates reporting modest growth in underlying EBITDA on a constant currency basis.
Share performance of NUF
Shares of Nufarm closed 0.37% down at AUD 5.37 apiece on 31 July 2023 with a market capitalisation of AUD 2.05 billion. Including this, the share price has dropped by 8.52% in the past six months and increased by 4.07% in the last 12 months.
The 52-week high of NUF is AUD 6.41 per share, 19.36% higher than today’s closing price. The 52-week low is AUD 4.85 per share, 9.68% lower than the existing stock price.

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, currency, is 31 July 2023. The reference data in this report has been partly sourced from REFINITIV.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.